We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going to take a look at where ...
Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...
CRISPR Therapeutics (NASDAQ: CRSP) stock climbed 7% after receiving an upgrade from Evercore ISI, shifting from an In Line rating to Outperform. The biotechnology company, known for its CRISPR/Cas9 ...
Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback